Lupus Research Alliance Welcomes Self-Injectable Form of Belimumab

NEW YORK, July 21, 2017 /PRNewswire-USNewswire/ -- The Lupus Research Alliance congratulates GlaxoSmithKline (GSK) on the approval of belimumab (Benlysta®) by the U.S. Food and Drug Administration as a self-injectable (subcutaneous) formulation for people with systemic lupus erythematosus...